Lucid Diagnostics Stock (NASDAQ: LUCD) stock price, news, charts, stock research, profile.
Open | $0.769 |
Close | $0.723 |
Volume / Avg. | 269.597K / 160.221K |
Day Range | 0.701 - 0.780 |
52 Wk Range | 0.740 - 1.850 |
Market Cap | $34.924M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 21 |
Short Interest | 2.92% |
Days to Cover | 1.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lucid Diagnostics (NASDAQ: LUCD) through any online brokerage.
Other companies in Lucid Diagnostics’s space includes: Precision Optics Corp (NASDAQ:POCI), LENSAR (NASDAQ:LNSR), Modular Medical (NASDAQ:MODD), QT Imaging Holdings (NASDAQ:QTI) and NeuroOne Medical Tech (NASDAQ:NMTC).
The latest price target for Lucid Diagnostics (NASDAQ: LUCD) was reported by Needham on Friday, April 12, 2024. The analyst firm set a price target for 2.50 expecting LUCD to rise to within 12 months (a possible 245.35% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $0.7239 last updated April 23, 2024 at 4:26 PM EDT.
There are no upcoming dividends for Lucid Diagnostics.
Lucid Diagnostics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Lucid Diagnostics.
Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.